Cipla Set To Launch Favipiravir Drug For Treatment Of COVID Patients

Pharmaceutical firm Cipla is all set to launch Favipiravir, developed by the Council of Scientific and Industrial Research (CSIR) in a cost-effective process, for the treatment of COVID-19 patients,...

from NDTV News - Latest https://ift.tt/2ORjxma
https://ift.tt/eA8V8J July 24, 2020 at 06:53AM

Comments

Popular posts from this blog

Mark Walter, Lulla Brothers Under Spotlight Over Multi Million Dollar Embezzlement Allegations: Report